1. HOME
2. Research Insight
3. Market Leader - Patient Registry Software Market

The global patient registry software market is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The growth of this market is mainly attributed to the shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions. However, shortage of trained and skilled resources and privacy and data security related concerns hampered market growth to an extent.

The prominent players operating in this market include Phytel, Inc. (US), IQVIA Holdings, Inc. (US), OpenText Corporation (Canada), ImageTrend, Inc. (US), FIGmd, Inc. (US), Syneos Health Inc. (US) and McKesson Corporation (US).These players adopted the strategies of partnerships, agreements, and acquisitions to expand their presence in the global patient registry software market.

To know about the assumptions considered for the study download the pdf brochure

Phytel

Phytel dominated the patient registry market in 2019. The company’s leading position can be attributed to its broad product portfolio and wide geographic presence. The company mainly focuses on providing PHM solutions to government organizations, TPAs, companies, hospitals, and research centers. The company has a wide geographical presence encompassing the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has shown a focus on partnerships for growth.

IQVIA Holdings

IQVIA Holdings is the second-largest player in the patient registry software market. It offers a wide range of software and solutions. The company has a wide R&D platform with data spanning 300,000+ clinical investigators, 487 indications, and 18 therapeutic areas. Besides, the company’s highly skilled workforce gives it a competitive edge. The company is also providing hospital partners with a COVID-19 registry platform and technology-powered trial matching solution. Moreover, it has focused on expanding its presence through partnerships and product launches.

OpenText Corporation

OpenText Corporation’s leading position in the global market can be attributed to its comprehensive product portfolio, consisting of Liaison’s ALLOY Health: Registry, Liaison ALLOY Health: BMT Registry, OpenText EIM solutions, OpenText Alloy, and OpenText MIPS Health Registry. Inorganic strategies have been an important part of the company’s growth in recent years. It conducted several acquisitions in 2018–2019 to enhance its market share.

FIGmd

FIGmd was the fourth-largest market player in 2019. It has succeeded in this market, mainly due to a strong product portfolio and a focus on inorganic growth. During 2017–2018, the company entered into several partnerships with various companies and organizations such as eClinical Works (US) and the College of American athologists (CAP) (US) to enhance its market share, service offerings, and customer support.

Related Reports:

Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]